Palvella Therapeutics, Inc.
PVLA
$120.57
-$5.22-4.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 246.25% | -30.65% | 347.43% | 384.51% | 928.93% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.90% | -56.23% | 161.68% | 335.18% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 231.36% | -33.15% | 310.13% | 380.62% | -- |
|
|
|||||
| Total Current Assets | 231.36% | -33.15% | 310.13% | 380.62% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 232.03% | -32.50% | 310.13% | 380.62% | -- |
|
|
|||||
| Total Accounts Payable | 22.56% | 0.20% | 11.21% | 215.15% | -- |
| Total Accrued Expenses | 43.93% | -14.91% | -15.61% | -20.68% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -65.75% | -8.40% | 1,058.51% | 1,156.71% | -- |
| Total Other Current Liabilities | -65.75% | -8.40% | 1,058.51% | 1,156.71% | -- |
| Total Current Liabilities | 1.47% | -5.77% | 35.06% | 118.79% | -- |
|
|
|||||
| Total Current Liabilities | 1.47% | -5.77% | 35.06% | 118.79% | -- |
| Long-Term Debt | 50.48% | 48.72% | -33.44% | -26.83% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.26% | 23.92% | 35.54% | 37.01% | -- |
| Total Liabilities | 31.78% | 23.21% | -14.69% | 1.56% | -- |
|
|
|||||
| Common Stock & APIC | 143.45% | 4.48% | 6,677.90% | 7,203.16% | -- |
| Retained Earnings | -48.37% | -44.50% | -36.70% | -34.19% | -- |
| Treasury Stock & Other | 3,266.67% | 2,666.67% | -- | -- | -- |
| Total Common Equity | 318.00% | -55.30% | 144.26% | 159.11% | 174.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 318.00% | -55.30% | 144.26% | 159.11% | 174.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 318.00% | -55.30% | 330.24% | 567.29% | 1,532.40% |
|
|
|||||